RT Journal Article
SR Electronic
T1 Progress in Diagnosis and Treatment of Small Cell Carcinoma of the Cervix
JF Chinese Journal of Clinical Oncology
JO Cancer Biol Med
FD China Anti-Cancer Association
SP 367
OP 371
DO 10.1007/s11805-007-0367-2
VO 4
IS 5
A1 Wei, Deying
A1 Tan, Yingchun
A1 Liu, Ming
A1 Tan, Chunsheng
YR 2007
UL http://www.cancerbiomed.org/content/4/5/367.abstract
AB Small cell carcinoma of the cervix (SCCC) belongs to the neuroendocrine carcinomas, and it is a rare gynecological tumor of high-potential malignancy. It has a poorer prognosis compared to cervical squamous cancer or adenocarcinoma, and the therapeutic regimen of the disease differs. Diagnosis is based on pathomorphological characteristics, i.e., the small and round cancer cells (oat cell) which are uniform in shape and size, with the immunohistochemical marker helpful for diagnosis. Combined therapy is first recommended. Postoperative chemotherapy with platinum/etoposide (PE), vincristine/adriamycin/cyclophosphamide (VAC) and taxel/carboplatin (TP) can markedly improve the prognosis of early SCCC patients.